(MedPage Today) — CHICAGO — Classifying inflammatory subphenotypes of acute respiratory distress syndrome (ARDS) with bedside lab testing was feasible and showed differences in 60-day mortality, according to a prospective cohort study.
Among…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
